Granahan Investment Management’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
Other funds holding AUTL
SP
NCM
FM
TAM
PG
Granahan Investment Management's AUTL Position: Q4 2021 in Review
Granahan Investment Management sold out of Autolus Therapeutics (AUTL) in Q4 2021, closing a stake of 176,683 shares — an estimated $1.16M sold.
Granahan Investment Management first reported a position in AUTL in Q2 2018 and held it in 14 quarters. The position peaked at $6.91M in Q3 2020. 73 funds tracked by Wall St. Rank hold AUTL as of Q4 2021.
- Granahan Investment Management reported no remaining Autolus Therapeutics position as of Q4 2021 after selling out during the quarter.
- Granahan Investment Management sold 176,683 Autolus Therapeutics shares in Q4 2021, an estimated $1.16M.
- Granahan Investment Management first reported a position in Autolus Therapeutics in Q2 2018 and held it in 14 quarters.
- Granahan Investment Management's Autolus Therapeutics position peaked at $6.91M in Q3 2020.
- 73 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2021.
Based on Granahan Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.